Migraine Linked to Auditory Disorders Like Tinnitus

A 2026 review in the *Journal of Neurology* reframes migraine as a “systemic disorder of multisensory sensitization.” This means the condition affects more than just the head. The authors, led by Wandi Xu, Ni Zhai, and Jingyu Chen, argue that hearing problems are a prevalent but often ignored part of migraine’s clinical picture. Their analysis of epidemiological, audiological, and pathophysiological data offers a new framework for understanding why so many people with migraine also struggle with their hearing.

## Migraine’s High Prevalence of Auditory Symptoms

The numbers are significant. Epidemiological data compiled by Xu and colleagues show that **15% to 49% of individuals with migraine report comorbid auditory symptoms.** These can include sensorineural hearing loss, the phantom perception of sound known as tinnitus, and sound sensitivity or hyperacusis. The connection isn’t just subjective. Nearly **two-thirds of migraine patients exhibit abnormalities in auditory electrophysiological tests**, which measure how the brain and auditory nerve respond to sound. This indicates that the link is not coincidental but has a biological basis, even between migraine attacks.

## The Three-Axis Model: From Inner Ear to Brain

The review proposes that migraine-related auditory dysfunction operates across a “peripheral-to-central continuum.” This involves three interacting axes of pathology.

First, **anatomical and hydrodynamic vulnerabilities** can lead to localized microvascular ischemia (reduced blood flow) and abnormal fluid exchange between the brain and inner ear. This may explain why some people with migraine experience fluctuating hearing or pressure sensations.

Second, **localized neurochemical imbalances** disrupt inner ear homeostasis. The paper highlights glutamate excitotoxicity, abnormal neuropeptide signaling (like that involving CGRP, a key migraine molecule), and innate immune activation. These processes can damage delicate cochlear structures.

Third, and perhaps most critically, **central sensitization** facilitates neural network plasticity. The brain’s pain and sound processing networks become hyper-excitable. This leads to impaired efferent gating—the brain’s inability to filter out irrelevant sounds—and thalamocortical dysrhythmia, a dysfunctional rhythm between the brain’s relay station and its outer layer. This axis is particularly relevant for conditions like hyperacusis and tinnitus, where the brain’s interpretation of sound is altered. This concept of central sensitization shares similarities with mechanisms discussed in our article on PTSD and Tinnitus: Shared Pathways.

## A New Framework for Treatment Strategies

Current clinical management is often fragmented. The authors state that optimal care is constrained by incomplete mechanistic understanding and variable assessment methods. To address this, they categorize current and emerging therapeutic strategies by specific clinical objectives, moving from general migraine control to targeted auditory protection.

1. **Blocking Upstream Migraine Pathways:** This foundational approach uses established migraine preventatives and CGRP-targeting medications. The goal is to reduce the overall burden of migraine attacks, which may indirectly lessen auditory symptoms by calming the sensitized nervous system.
2. **Protecting the Cochlear Microenvironment:** This strategy aims to shield the inner ear from the neurochemical storms of migraine. It could involve antioxidants, neuroprotective agents, or treatments targeting the immune response within the cochlea.
3. **Correcting Central Hypersensitivity:** Treatments here focus directly on the overactive auditory and pain networks in the brain. This includes sound therapy, cognitive behavioral therapy (CBT), and neuromodulation techniques. The success of such brain-focused therapies often depends on individual factors, much like how CBT-I Outcomes: Baseline Depression Predicts Long-Term Results on our partner site, sleepscience.space, highlights the importance of personalized approaches in behavioral treatments.

## Practical Implications for Patients and Clinicians

For patients, this research validates that their auditory symptoms are likely a real and biologically connected part of their migraine disorder, not a separate or imagined issue. It argues for a more holistic assessment. A person with migraine complaining of new tinnitus or sound intolerance should receive a comprehensive audiological evaluation alongside their neurological care.

For clinicians, the review is a call for cross-disciplinary management. Otolaryngologists, audiologists, and neurologists need to share a common understanding of these mechanisms. The proposed three-axis model provides a roadmap for developing more precise clinical phenotypes. For instance, a patient whose primary issue is hyperacusis might benefit most from strategies targeting central sensitization, while one with objective, low-frequency hearing loss might need a focus on cochlear microenvironment protection.

This framework, as detailed in the review “Migraine and auditory dysfunction: beyond comorbidity” (PMID: 42371148), aims to catalyze targeted research. Future studies must rigorously validate these mechanistic links to move from a model of comorbidity to one of integrated pathophysiology. This shift is essential for improving early identification and creating effective, personalized treatment plans for the large number of people whose migraine disease profoundly affects how they hear the world. For more on the clinical connections, readers can explore our existing resource on Migraine and Hearing Disorders Explained.